Ackman Attacks Allergan CEO In Push For $46B Valeant Deal
Activist investor Bill Ackman on Monday took aim at the dual chairman and chief executive of Botox maker Allergan Inc., saying he has a "disabling" conflict of interest that prevents him...To view the full article, register now.
Already a subscriber? Click here to view full article